Trials / Conditions / Pancreatic Adenosquamous Carcinoma
Pancreatic Adenosquamous Carcinoma
5 registered clinical trials studyying Pancreatic Adenosquamous Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Ad NCT07491445 | Revolution Medicines, Inc. | Phase 3 |
| Active Not Recruiting | The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Assoc NCT06115499 | Alliance for Clinical Trials in Oncology | Phase 2 / Phase 3 |
| Recruiting | APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy NCT04858334 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer NCT04340141 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Recruiting | Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma NCT04157127 | Diakonos Oncology Corporation | Phase 1 |